World-renowned industry analyst firm, Frost & Sullivan, has recognized BrightInsight with its 2020 Global Entrepreneurial Company of the Year Award for our work advancing and accelerating digital health innovation in biopharma and medtech.
Each year, Frost & Sullivan presents this award to the company that demonstrates excellence devising a strong growth strategy and robustly implementing it. The recipient must show strength in product and technology innovation, leadership in customer value, as well as speed in responding to market needs.
The Global Entrepreneurial Company of the Year Award looks at emerging market players and recognizes best practices that position the company for future growth excellence. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify industry best practices.
"BrightInsight provides a sustainable competitive advantage, strengthening the software-as-a-service (SaaS) model and its status as the leading global regulated IoT solution provider. Overall, it is well positioned to capture significant market share in this fast-growing segment," states Nitin Naik, vice president at Frost & Sullivan.
Access the report to learn more about:
- The importance of privacy, security, regulatory and quality for digital health products
- How to unlock the most value from regulated digital health use cases
- How BrightInsight’s regulated platform compares to the competition